THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Lucila Garcia-Contreras to Lung

This is a "connection" page, showing publications Lucila Garcia-Contreras has written about Lung.
Connection Strength

3.376
  1. Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs. Int J Pharm. 2018 Oct 05; 549(1-2):306-316.
    View in: PubMed
    Score: 0.511
  2. Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs. J Pharm Sci. 2017 01; 106(1):331-337.
    View in: PubMed
    Score: 0.453
  3. Mechanisms of absorption and elimination of drugs administered by inhalation. Ther Deliv. 2013 Aug; 4(8):1027-45.
    View in: PubMed
    Score: 0.361
  4. Implications of increased nanoparticle absorption by infant lungs: future prospects. Ther Deliv. 2013 Apr; 4(4):417-20.
    View in: PubMed
    Score: 0.353
  5. Pharmacokinetics of sequential doses of capreomycin powder for inhalation in guinea pigs. Antimicrob Agents Chemother. 2012 May; 56(5):2612-8.
    View in: PubMed
    Score: 0.326
  6. In vivo animal models for drug delivery across the lung mucosal barrier. Adv Drug Deliv Rev. 2007 Sep 30; 59(11):1133-51.
    View in: PubMed
    Score: 0.239
  7. Evaluation of novel particles as pulmonary delivery systems for insulin in rats. AAPS PharmSci. 2003; 5(2):E9.
    View in: PubMed
    Score: 0.173
  8. Immediate and short-term cellular and biochemical responses to pulmonary single-dose studies of insulin and H-MAP. Pharm Res. 2001 Dec; 18(12):1685-93.
    View in: PubMed
    Score: 0.161
  9. Immunological and toxicological implications of short-term studies in animals of pharmaceutical aerosol delivery to the lungs: relevance to humans. Crit Rev Ther Drug Carrier Syst. 2001; 18(4):387-431.
    View in: PubMed
    Score: 0.151
  10. SHetA2 Dry Powder Aerosols for Tuberculosis: Formulation, Design, and Optimization Using Quality by Design. Mol Pharm. 2018 01 02; 15(1):300-313.
    View in: PubMed
    Score: 0.122
  11. Liquid chromatographic determination of CPZEN-45, a novel anti-tubercular drug, in biological samples. J Pharm Biomed Anal. 2014 Jan; 88:370-6.
    View in: PubMed
    Score: 0.091
  12. Pulmonary immunization of guinea pigs with diphtheria CRM-197 antigen as nanoparticle aggregate dry powders enhance local and systemic immune responses. AAPS J. 2010 Dec; 12(4):699-707.
    View in: PubMed
    Score: 0.074
  13. Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity. AAPS J. 2010 Sep; 12(3):338-47.
    View in: PubMed
    Score: 0.072
  14. Dry powder PA-824 aerosols for treatment of tuberculosis in guinea pigs. Antimicrob Agents Chemother. 2010 Apr; 54(4):1436-42.
    View in: PubMed
    Score: 0.071
  15. Immunization by a bacterial aerosol. Proc Natl Acad Sci U S A. 2008 Mar 25; 105(12):4656-60.
    View in: PubMed
    Score: 0.062
  16. Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model. Antimicrob Agents Chemother. 2007 Aug; 51(8):2830-6.
    View in: PubMed
    Score: 0.059
  17. Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the treatment of tuberculosis in the guinea pig. J Antimicrob Chemother. 2006 Nov; 58(5):980-6.
    View in: PubMed
    Score: 0.056
  18. Facilitation of pulmonary insulin absorption by H-MAP: pharmacokinetics and pharmacodynamics in rats. Pharm Res. 2001 Dec; 18(12):1677-84.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES